Two prior RCTs (CADISS and TREAT-CAD) investigated this topic, each with distinct designs. The CADISS trial found no statistically significant difference in primary outcomes between antiplatelet and anticoagulation therapy for extra-cranial dissection. However, the TREAT-CAD trial failed to de...
Comments
at University of Colorado, Climate & Health Dept I've been leaning more towards anticoagulation for...
I agree with Dr. @Farooqui. My approach to stroke prevention (based on insights from the three trials and subgroup analyses) for extracranial dissection is case-based. If there are high-risk features; occlusion, thrombus, ischemic stroke, or distal embolic detection on TCD, I use anticoagulation, us...
I've been leaning more towards anticoagulation for...